All German Center for Infection Research articles
-
NewsAiCuris and DZIF sign Collaboration and License Option Agreement
AiCuris Anti-infective Cures AG and the German Center for Infection Research (DZIF) have announced the signing of a collaboration and license option agreement.
-
NewsTrial offers insights into treatment options for bloodstream infections
An international clinical trial has been able to gain decisive new insights into the treatment of bloodstream infections with the pathogen Staphylococcus aureus (SAB).
-
NewsNew antibiotics make TB bacterium less pathogenic for humans
Researchers have identified new, antibiotic molecules that target Mycobacterium tuberculosis and make it less pathogenic for humans.
-
NewsResearchers decode new antibiotic clovibactin
Researchers have discovered and deciphered the mode of action of a new antibiotic, clovibactin, which is derived from a soil bacterium.
-
NewsMonoclonal antibody shows promise for treating chronic hepatitis B and D infections
In a preclinical study, the potential of an engineered investigational human monoclonal antibody for the treatment of chronic hepatitis B and hepatitis D has been demonstrated.
-
NewsAchilles heel is uncovered in Helicobacter pylori
Researchers have discovered a weakness in the bacterium Helicobacter pylori, which could be exploited to develop new drugs.
-
NewsResearcher receives €1.5m from ERC to probe insecticide resistance in malaria transmission
Dr Victoria Ingham, a scientist at Heidelberg Medical Faculty and the German Center for Infection Research (DZIF), has been awarded an ERC Starting Grant of €1.5 million for her research on the infectious disease malaria.
